Efficacy and safety of pilocarpine hydrochloride ophthalmic solution USP 1.25% w/v versus placebo ophthalmic solution for the treatment of presbyopia – A multicentric clinical trial
Pilocarpine 1.25% effectively improves near vision in presbyopia, with sustained benefits up to day 30 and potential long-term adaptability.
Authors
- Nivean Madhivanan
- Sabyasachi Sengupta (ORCID: https://orcid.org/0000-0001-7441-5856)
- Amlan Datta (ORCID: https://orcid.org/0000-0003-2644-4905)
- Parul Singh
- Tejal Garasiya
- Vidya Ajila
Institutions
- Aravind Eye Hospital (IN)
- Ganesh Shankar Vidyarthi Memorial Medical College (IN)
- Department of Pharmaceuticals (IN)
- Jyotirmay Eye Clinic (IN)
- Biocon (India) (IN)
- Directorate of Medicinal and Aromatic Plants Research (IN)
- Vasan Eye Care Hospital (IN)
- ICMR-National Institute of Virology (IN)
Publication Details
- Journal
- Indian Journal of Ophthalmology
- Published
- 2025-08-29
- DOI
- https://doi.org/10.4103/ijo.ijo_680_25
- Citations
- 4
- Primary Topic
- Ophthalmology and Visual Impairment Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.42